Page 156 - Multidisipliner Covid 19
P. 156
BÖLÜM 09
4. Cheng P, Zhu H, Witteles RM, et al. Cardiovascular Risks in Patients
with COVID-19: Potential Mechanisms and Areas of Uncertainty. Curr
Cardiol Rep. 2020;22(5):1-6. doi:10.1007/s11886-020-01293-2
5. Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular
Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med.
Published online 2020:1-8. doi:10.1056/nejmoa2007621
6. ACC’s COVID-19 Hub - American College of Cardiology. Accessed
June 24, 2020. https://www.acc.org/latest-in-cardiology/features/accs-
coronavirus-disease-2019-covid-19-hub#sort=%40fcommonsortdate
90022 descending
7. European Society of cardiology. ESC Guidance for the Diagnosis and
Management of CV Disease during the COVID-19 Pandemic. Published
online 2020:1-115.
8. Aktoz M, Altay H, Aslanger E, et al. Türk Kardiyoloji Derneği Uzlaşı
Raporu: COVID-19 Pandemisi ve Kardiyovasküler Hastalıklar Konu-
sunda Bilinmesi Gerekenler (25 Mart 2020). Turk Kardiyol Dern Ars.
2020;48:1-3. doi:10.5543/tkda.2020.97198
9. Radzikowska U, Ding M, Tan G, et al. Distribution of ACE2, CD147,
CD26 and Other SARS_CoV_2 Associated Molecules in Tissues and
Immune Cells in Health and in Asthma, COPD, Obesity, Hypertension,
and COVID_19 Risk Factors.; 2020. doi:10.1111/all.14429
10. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality
of adult inpatients with COVID-19 in Wuhan, China: a retrospective
cohort study. Lancet. 2020;395(10229):1054-1062. doi:10.1016/S0140-
6736(20)30566-3
11. Guo T, Fan Y, Chen M, et al. Cardiovascular Implications of Fatal
Outcomes of Patients with Coronavirus Disease 2019 (COVID-19).
JAMA Cardiol. 2020;2019. doi:10.1001/jamacardio.2020.1017
12. Hendren NS, Drazner MH, Bozkurt B, Cooper LT. Description and
Proposed Management of the Acute COVID-19 Cardiovascular Syn-
drome. Circulation. 2020;141(23):1903-1914. doi:10.1161/CIRCULA-
TIONAHA.120.047349
13. Sala S, Peretto G, Gramegna M, et al. Acute myocarditis presenting as
a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respira-
tory infection. Eur Heart J. 2020;41(19):1861-1862. doi:10.1093/eur-
heartj/ehaa286
14. Tavazzi G, Pellegrini C, Maurelli M, et al. Myocardial localization of
155